Search results
Bristol Myers drug combo fails to meet main goal in kidney cancer trial
Reuters via Yahoo News· 2 years agoYervoy and top selling cancer drug Opdivo - is already approved in the United States as a first line...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Reuters via AOL· 2 months agoThe treatment, tested in patients with advanced hepatocellular carcinoma (HCC), met the main goal of...
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney...
Benzinga via Yahoo Finance· 4 months agoBristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab)...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
IBD Stock Of The Day: Bristol Myers Eyes Breakout After $4.1 Billion Buyout
Investor's Business Daily· 2 years agoBristol Myers Squibb is the IBD Stock Of The Day as BMY stock bounds off its 50-day line, presenting...
Bristol Myers Stock Yo-Yoes, Trying To Avoid A Fourth Day In The Red, On So-So Earnings
Investor's Business Daily· 4 months agoBristol Myers Squibb topped Wall Street's fourth-quarter expectations on Friday, but BMY stock...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 12 months agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 2 weeks agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Bristol Myers (BMY) to Buy Cancer Drug-Maker RayzeBio for $4.1B
Zacks via Yahoo Finance· 5 months agoBristol Myers (BMY) is set to acquire RayzeBio for $4.1 billion to strengthen and diversify its...
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%
Zacks via Yahoo Finance· 1 year agoIovance (IOVA) to acquire worldwide rights to an IL-2 product already approved by FDA for two cancer...